Sammaan Capital Promoters Infuse Rs 906 Crore Via Warrant Conversion

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Sammaan Capital Promoters Infuse Rs 906 Crore Via Warrant Conversion

Sammaan Capital Ltd has issued 8.68 crore equity shares to promoter Avenir Investment RSC Ltd following the conversion of Tranche I warrants. The company received Rs 905.86 crore, raising promoter stake from 28.34% to 33.32%.

Sammaan Capital Completes Rs 906 Crore Warrant Conversion

Promoter shareholding in Sammaan Capital has increased to 33.32% following a major capital infusion. The company successfully converted 8.68 crore warrants into fully paid-up equity shares at an issue price of Rs 139 per share.

Reader Takeaway: Promoter confidence signaled by Rs 906 crore infusion; however, significant warrant overhang remains for potential future dilution.

What just happened

Sammaan Capital has allotted 8,68,92,966 equity shares to its promoter, Avenir Investment RSC Ltd, upon the exercise of Tranche I warrants. The company realized a total consideration of Rs 905.86 crore from this exercise. This move has pushed the promoter's stake from 28.34% to 33.32%.

Why this matters

The influx of over Rs 900 crore strengthens the company's capital base. By exercising these warrants at Rs 139 per share, the promoter has demonstrated continued commitment to the company's growth and capital structure.

The backstory

The company previously issued a larger tranche of warrants to the promoter. Following this conversion, the promoter still holds 21,97,97,569 warrants. These remaining warrants are exercisable in one or more tranches until September 30, 2027.

What changes now

The company’s paid-up equity share capital has increased. It now stands at approximately Rs 249.89 crore, represented by 1,24,84,36,597 fully paid-up equity shares of Rs 2 face value, alongside 30,13,213 partly paid-up shares.

Risks to watch

Investors should monitor the remaining 21.97 crore warrants. If fully exercised, the promoter's shareholding could rise further to 43.28%. While this signals promoter support, it also suggests potential future equity dilution for existing shareholders when those remaining warrants are converted.

What to track next

Watch for future disclosures regarding the exercise of the remaining warrant tranches before the September 2027 deadline and how the company utilizes the newly infused capital for its lending or growth operations.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.